---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-031419"
form_type: "8-K"
ticker: "EUDA"
cik: "0001847846"
company_name: "EUDA Health Holdings Ltd"
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-21T23:53:22.106689+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 8i Acquisition 2 shareholders approve EUDA Health business combination; 8.2M shares redeemed

## Summary
- All proposals approved at Nov 10 special meeting: business combination, name change to EUDA Health Holdings, stock issuance, and director election.
- 8,195,770 ordinary shares tendered for redemption at $10.0837 per share (~74% of outstanding shares).
- Shareholders may withdraw redemption requests until 5 p.m. ET on Nov 11, 2022.
- Five directors elected; effective upon consummation of the Business Combination.

## SEC filing metadata
- accession: 0001493152-22-031419
- form_type: 8-K
- ticker: EUDA
- cik: 0001847846
- company_name: EUDA Health Holdings Ltd
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-031419
- JSON: https://secwatch.observer/filing/0001493152-22-031419.json
- Plain text: https://secwatch.observer/filing/0001493152-22-031419.txt

## Key facts
- Shareholder Votes
  EUDA Health Holdings Ltd shareholders approved To approve the transactions contemplated under the SPA. at the 2022-11-10 meeting.
  - Proposal: merger approval
  - Outcome: passed
  - Meeting: 2022-11-10
  source text: PROPOSAL 1: To approve the transactions contemplated under the SPA. For Against Abstain Broker Non-Votes 8,314,452 1,030,751 24,192 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm
- Shareholder Votes
  EUDA Health Holdings Ltd shareholders approved To approve, for purposes of complying with applicable listing rules of the Nasdaq Global Market, the issuance of more than 20% of the issued and outstanding Ordinary Shares and the resulting change in control in connection with the Business Combination. at the 2022-11-10 meeting.
  - Proposal: merger approval
  - Outcome: passed
  - Meeting: 2022-11-10
  source text: PROPOSAL 3: To approve, for purposes of complying with applicable listing rules of the Nasdaq Global Market (“Nasdaq”), the issuance of more than 20% of the issued and outstanding Ordinary Shares and the resulting change in control in connection with the Business Combination. For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm
- Shareholder Votes
  EUDA Health Holdings Ltd shareholders approved To vote to elect five directors effective upon consummation of the Business Combination. at the 2022-11-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-11-10
  source text: PROPOSAL 4: To vote to elect five directors effective upon consummation of the Business Combination. Each of the director nominees received the following votes: Director Nominee Class For Withhold Wei Wen Kelvin Chen I 8,436,565 932,836 Thien Su Gerald Lim I 8,436,565 932,836 David Francis Capes I 8,436,565 932,836 Alfred Lim II 8,436,565 932,836 Kim Hing Chan II 8,436,565 932,836
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm
- Shareholder Votes
  EUDA Health Holdings Ltd shareholders approved To approve and adopt the following amendments and restatements of 8i amended and restated memorandum and articles of association: a) to amend the name of the combined company from "8i Acquisition 2 Corp." to "EUDA Health Holdings Limited"; and b) to adopt the amended and restated memorandum and arti at the 2022-11-10 meeting.
  - Outcome: passed
  - Meeting: 2022-11-10
  source text: PROPOSAL 2: To approve and adopt the following amendments and restatements of 8i amended and restated memorandum and articles of association: a) to amend the name of the combined company from “8i Acquisition 2 Corp.” to “EUDA Health Holdings Limited”; and For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0 2 b) to adopt the amended and restated memorandum and articles of association of the combined company (the “Amended and Restated Memorandum and Articles of Association”). For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.